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A plasmonic nanosensor (using gold nanorods) with inverse 
sensitivity is presented for circulating cell-free DNA 
quantification. The inverse sensitivity (i.e. the lower the 
analyte concentration, the higher the response intensity) is 
achieved by the unusual DNA concentration-dependent gold 
nanorod aggregation. This assay method can adjust the 
dynamic range by controlling the concentration of 
nanoparticles in solution.  
Currently, biopsy is the only method that can diagnose cancer 
with absolute certainty.1 This medical test involves the removal of 
tissue from the patient to determine the presence and extent of the 
abnormal cell growth. Several non-invasive alternatives have been 
developed, such as body fluid analysis.2–4 However, the lack of 
sensitivity and specificity of the most serum cancer biomarkers has 
prevented the use of body fluid analysis as definitive non-invasive 
sensing technique for cancer diagnostics.5,6 Nevertheless, the 
analysis of circulating cell-free DNA (cfDNA), i.e. extracellular and 
mostly double-stranded DNA found in nucleosomes7,8 and other 
complex species8-10 in blood, serum and plasma, has recently 
emerged as a promising new non-invasive liquid biopsy, which 
allows monitoring the patient’s therapeutic response and disease 
progression.11–13 Even though a few commercial kits are available, 
providing fast and easy-to-use DNA quantification, most of them are 
not able to cover all the physiological cfDNA concentration range. 
Furthermore, the ranges of concentrations of the analysed samples 
are frequently close to the limit of detection (LOD) of those kits, 
providing small intensity responses, that leads to a low reliability. 
Therefore, new assay concepts are required for a robust 
quantification of cfDNA at low concentration range, especially 
around the LOD. In analytical chemistry, the low reliability for low 
analyte concentrations near the LOD is a common problem. Thus 
signal amplification strategies, i.e. enzymatic amplification,14 
labelling the analyte with antibody conjugates15 or employing more 
sophisticate equipment,16 have been largely developed. However, 
those options also increase the complexity of the design and resource 
investment.   
In this work we propose an alternative analytical concept that 
overcomes the limitations of the commercial kits without involving 
complex designs. Particularly, we demonstrate a plasmonic 
nanosensor for cfDNA (or dsDNA) with inverse sensitivity, i.e. the 
lower the concentration of the analyte is, the higher the response 
intensity17 (Fig. S1). This concept employs 
hexadecyltrimethylammonium bromide (CTAB) coated gold 
nanorods (AuNRs) and their electrostatic interactions with dsDNA. 
The inverse sensitivity is achieved by the unusual DNA 
concentration-dependent AuNR aggregation, which can be measured 
by UV-Vis spectroscopy. This sensor is fast (10 min), 
straightforward and easy-to-use (one-step, mixture of 3 solutions). 
To the best of our knowledge, this is the second paper reporting the 
concept of inverse sensitivity that enables a higher reliability for low 
concentration analyte detection by creating inverse relationship 
between analyte concentration and signal output, which introduces 
high signal-to-noise ratio (SNR) for low concentration detection. 
The first report of such concept was performed by L. Rodriguez-
Lorenzo et al.,17 where enzymatic catalysed gold nanoparticle 
formation provides the inverse sensitivity for protein biomarker 
detection. In our current work, we further reinforce the inverse 
sensitivity concept for cfDNA detection. Despite of using plasmonic 
nanoparticles’ optical property as a signal output similarly, our 
method does not involve enzymes and is conceptually simpler 
without involving long experimental times and multi-step procedures. 
Furthermore, our concept allows for a tuneable dynamic range not 
existing in the first inverse sensitivity sensor. 
The AuNRs used in this work were synthesized by seed-
mediated method with CTAB as a surfactant,18 which results in a 
positively charged gold surface. When negatively charged molecules 
are mixed with AuNRs, the rods aggregate.19 Several reports have 
published apparently contradictory results, i.e. a few groups 
reporting the AuNR aggregation by dsDNA20,21 while others found 
that dsDNA can protect them against aggregation.22,23 We discover 
that the result of the interaction between dsDNA and AuNR is 
concentration dependent, and therefore both induction of AuNR 
aggregation and protection against aggregation occur depending on 
the dsDNA and AuNR concentrations. Both phenomena can be 
followed by the shift of the longitudinal localised surface plasmon 
resonance band (L-LSPR) as a consequence of the plasmon coupling 
between contiguous rods.  
Fig. 1A shows the UV-Vis spectra of AuNRs (optical density at 
890 nm, OD890 of 0.48) with aspect ratio (AR) of 4.9 mixed with 
dsDNA (in 8 mM Tris buffer) at different concentrations. The 
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dsDNA molecules were 180 base-pair long, which is the typical 
length of the cfDNA fragments originated from apoptotic cells.24 
The Tris buffer is the most common buffer used by the commercial 
DNA extraction kits.25 Since cfDNA is commonly adsorbed on other 
species in biological samples (e.g. proteins7,8 and lipid membranes8-
10), its extraction is an essential step prior to the analysis using any 
commercial quantification kit,26 and our plasmonic sensing method. 
Initially, the dsDNA induces the assembly of the rods, red-shifting 
the L-LSPR band from 890 to 995 nm at 2.5 nM. However, further 
addition of dsDNA promotes the opposite phenomenon, i.e. 
disaggregation of the rods. The L-LSPR band blue-shifts back, up to 
895 nm at 50 nM dsDNA. The aggregation and disaggregation is 
quantified using the absorbance ratio at 510 and 890 nm wavelengths 
(A510/A890) for different dsDNA concentrations in Fig. 1B. The 
limit of detection (LOD) is 2.5 nM, which is calculated as the lowest 
analyte concentration that is detected in the inverse-sensitivity 
regime, and the dynamic range is from 2.5 to 50 nM. The response 
curve of the sensor has been divided in two concentration regimes, 
i.e. below (green) and above (blue) the LOD, respectively. It is 
noteworthy that the below LOD regime presents normal sensitivity 
with increasing signal with the analyte concentration. This lower 
concentration regime is so narrow (5 % of the concentration of the 
full response curve) that can be neglected, yielding an inverse 
sensitivity sensor closer to the idealistic performance, i.e. zero 
response below the LOD. Additionally, the sample concentration 
within the higher concentration regime (i.e. the one with inverse 
sensitivity response) can be confirmed by diluting the sample for a 
second test. An increase of A510/A890 is expected if the sample is 
within this higher concentration regime. Otherwise a decrease of 
A510/A890 would be observed if it is in the lower concentration 
regime. Interestingly, the SNR at the LOD is highly enhanced by the 
inverse sensitivity, e.g. SNR at 2.5 nM is 63, in comparison to the 
conventional sensors, whose SNR at the LOD is 3 by definition.27 
Transmission electron microscopy (TEM) studies were 
performed to characterise the AuNRs assembly and disassembly at 
the nanoscale. Fig. 2A reveals well monodispersed AuNRs in the 
absence of dsDNA. After the addition of dsDNA of as low as 2 nM, 
the rods are assembled, yielding several micrometer sized aggregates 
(Fig. 2B). Upon further addition of dsDNA, e.g. 10 nM, initiates the 
disaggregation (Fig. 2C). At dsDNA concentration of 20 nM, the 
original AuNR dispersity is almost recovered and only small 
aggregates are present in the sample (Fig. 2D). These results are 
confirmed by dynamic light scattering (DLS), which shows a 
dramatic increase of the AuNR hydrodynamic radius from 8 to 110 
nm, after the initial addition of dsDNA, and its subsequent decrease 
back to 14 nm at higher dsDNA concentration (Fig. 2E).  
To gain a more complete understanding of the mechanism 
involved in the concentration-dependent interaction of the dsDNA 
with the AuNRs, the nanoparticle zeta potential was measured after 
the addition of different amounts of dsDNA. Fig. 3 shows an initial 
decrease in the AuNR zeta potential with the increase in the dsDNA 
concentration. The rapid decrease can be attributed to the screening 
of the CTAB positive charges by the dsDNA phosphate groups. 
Once the AuNR net charge has been neutralized, further additions of 
dsDNA induce a charge reversal and a slow negative increase of the 
nanoparticle electric potential. Zeta potential is one of the key 
parameters defining the repulsive forces among nanoparticles and 
colloidal stability.28 Therefore, its fast neutralization and subsequent 
negative increase resulted in the AuNR initial aggregation and the 
later disaggregation. This result is consistent with the zeta potential 
and the A510/A890 profiles, which show the range of dsDNA 
concentrations with zeta potential closer to zero is the range with 
           
Fig. 1 Characterization of AuNRs (OD890 = 0.48), mixed with 
different amounts of dsDNA (180bp) in 8 mM Tris buffer. (A) 
UV-Vis spectra at 0 nM (dashed line), 2, 5, 10, 20 and 40 nM 
DNA (solid lines). (B) Absorbance ratio intensities at 510 and 890 
nm as the function of DNA concentration. The lower and higher 
concentration regimes are highlighted in green and blue, 
respectively.  
            
            
                
Fig. 2 Characterization of AuNR aggregation and disaggregation 
induced by dsDNA. TEM images at dsDNA concentrations of 
(A) 0, (B) 2, (C) 10 and (D) 20 nM. (E) Measures of AuNR 
hydrodynamic radius at 0, 2 and 10 nM dsDNA by DLS. The 
radius distributions have been offset vertically for clarity. 
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higher aggregation. 
To complement the concentration dependent charge density 
observations from the zeta potential experiments, we designed an 
experiment to study the relative positions between AuNRs and 
dsDNA. In this experiment, the dsDNA molecules were saturated by 
thiazole orange (TO), i.e. an intercalation dye that increase its 
fluorescence quantum yield 18900-fold upon binding to DNA,29 at 
molar ratio of 1 : 40.  The fluorescence of the resulting dsDNA-TO40 
can be quenched by AuNRs when they are in close proximity 
through nanoparticle surface energy transfer mechanism.30 Therefore, 
measuring the fluorescent emission of the dsDNA-TO40 can provide 
information about their relative position to the AuNR surface. Fig. 
4A shows the emission of dsDNA-TO40 solutions (0-50 nM), same 
concentration range as used in the nanorod aggregation study, in the 
absence and presence of AuNRs (OD890 = 0.48). In the absence of 
AuNRs, the fluorescence intensity at 535 nm (maximum emission 
wavelength) is linearly proportional to the concentration of the 
dsDNA-TO40 complex as expected (Fig. 4B). However, if the 
measured solution contains AuNRs, the fluorescence is almost 
totally quenched. Fig. 4C compares the fluorescence emission of 
dsDNA-TO40 in the presence of AuNRs and the AuNR aggregation 
profile measured with DNA without the intercalation dye. In the 
range of concentrations from 0 to 20 nM, where the rods are initially 
aggregated and later start disaggregating, all the fluorescence is 
quenched. The fluorescence intensity begins increasing after most 
part of the AuNRs have been disaggregated, e.g. dsDNA-TO40 
concentrations higher than 20 nM.  
 Based on the collective observations, we propose a mechanism 
for the DNA concentration-dependent AuNR aggregation and re-
dispersion. Initially, the dsDNA molecules are adsorbed on the 
AuNR surface by electrostatic interactions, leading to total dsDNA-
TO40 fluorescence quenching. At the lower DNA concentration 
regime (<2.5 nM), the electrostatic interactions between the dsDNA 
molecules and the AuNRs drive the initial aggregation, due to the 
decrease on the nanoparticle positive charge, and this process 
continue until the AuNRs have zero net charge. When DNA 
concentration increases further, more nucleic acids continue to 
adsorb on the AuNR surface, as evidenced by the nearly total 
quenching of the dsDNA-TO40 emission up to ~20 nM, as well as 
the pickup of the nanoparticle negative charge. The slow negative 
charge increase is accountable for the disaggregation process at 
higher DNA concentration regime (> 2.5 nM). At concentrations 
above 20 nM, we hypothesize that the AuNR are mostly covered and 
the excess dsDNA chains have little access to the CTAB gold 
surface and thus the fluorescence emission starts to pick up. Those 
free-DNA molecules have little to non-effect on the nanoparticle 
disaggregation, based on the small A510/A890 changes observed at 
concentrations higher than 20 nM. This unique DNA concentration 
dependent tuning of AuNR surface charge is the key of the inverse 
sensitivity. 
One major issue for detecting cfDNA and other nuclear acids in 
clinical samples is that the concentrations vary widely in those 
samples. To take full advantage of the inverse sensitivity method 
described here, it is important to tune the dynamic ranges of the 
detection so that the highest inverse sensitive area matches the 
cfDNA concentration in the samples. Toward this goal, we have 
changed the AuNR concentration in solution in order to adjust the 
dynamic range of the sensor and its section with higher SNR to 
different common ranges previously published in the literature.  
Fig. 5 depicts the aggregation profile of AuNR solutions at five 
different concentrations, i.e. OD890 of 0.92, 0.48, 0.22, 0.08 and 0.05. 
The LOD was found to increase with the AuNR concentration, e.g. 
10 nM for the most concentrated solution, relative to 0.2 nM for the 
most diluted one. The AuNR concentration also affects the dynamic 
range, increasing it and shifting it, e.g. from 0.2 to 2 nM and 10 to 
100 nM for the AuNR solutions with OD890 of 0.05 and 0.92, 
respectively. The combination of the five AuNR solutions yields a 
sensor that is sensitive enough to monitor the cfDNA levels 
associated with a wide range of cancer types (Table S2).  
 
Fig. 4 (A) Fluorescence emission of dsDNA-TO40 solutions in the 
absence and presence of AuNRs (OD890 = 0.48), respectively. (B) 
Emission intensities of different dsDNA-TO40 solutions at 
emission wavelength of 535 nm in the absence (orange) and 
presence (purple) of AuNRs. (C) Comparison between the 
fluorescence emission of dsDNA-TO40 in the presence of AuNR 
and their aggregation profile. All measures were done with an 
excitation wavelength of 490 nm. 
            
Fig. 3 Comparison between the effect of dsDNA concentration on 
the AuNR zeta potential (red) and the A510/A890 (blue). The region 
of concentrations with higher AuNR aggregation is highlighted in 
pale blue. 
COMMUNICATION Journal Name 
4 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 2012 
In summary, we have developed a plasmonic nanosensor with 
inverse sensitivity, exploiting the unique DNA concentration-
dependent AuNR aggregation/re-dispersion profile for cfDNA 
detection. A mechanism based on the change of the AuNR electric 
potential by the adsorption of dsDNA molecules at two regimes of 
lower and higher concentrations has been proposed to account for 
the inverse response of the sensor. The LOD and the dynamic range 
of this method can be adjusted by controlling the AuNR 
concentration in solution, allowing tunable sensor response curve 
and covering a wide range of cfDNA concentrations linked to cancer 
diagnosis and prognosis. The lowest LOD reached by this method is 
0.2 nM with an overall dynamic range of 0.2 to 100 nM. Notably, 
this is the second report of inverse sensitivity, relative to a previous 
one involving enzymatic reaction. The assay is conceptually simple, 
fast, easy-to-use and compatible with cfDNA extraction medium. 
This study further reinforces the breakthrough strategy of enhancing 
the reliability of low concentration detection, by literally introducing 
high SNR, which is often failed in the normal sensitivity sensing and 
signal amplification strategies.  
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